Clinical Studies

Four Peaks Neurology is collaborating with Clinical Endpoints to conduct clinical trials with the aim of testing the efficacy and safety of new medicines and treatment options that can potentially treat and prevent illness or disease.

Clinical Endpoints is conducting an array of studies that reach a wide variety of neurologic conditions. Below are some of the studies we are currently recruiting for. If you believe you qualify for a clinical trial, or if you have any questions regarding selection for a clinical trial, please contact Clinical Endpoints [click here] or contact your FPN provider.

Inhibikase

If you are a patient between 30-80 years old, you’ve been diagnosed with Parkinsons Disease, you are not currently receiving anti-parkinsonian therapy, and you don’t suffer significant hallucinations or orthostatic hypertension, then you are likely highly suited for this clinical trial!

Subject of Study: Early Parkinson’s Disease
Length of Study: 18 Weeks
Number of in-person visits: 6
Compensation: $100/visit completed, $900 total if entire study is completed.

Banner Life Sciences “SIMPLE”

If you are a patient with a relapsing form of multiple sclerosis, you recently started Bafiertam, you have not been taking it for more than 90 days, and you are not on a government funded prescription drug program, then you are likely highly suited for this clinical trial!

Subject of Study: MS
Length of Study: 12 Weeks
Number of in-person visits: 4
Compensation: $150/visit completed, $450 total.

UCB PD0060 “Atlantis”

If you are a patient between 35-80 years old, you have been diagnosed with Parkinsons Disease for five or more years, you have a minimum of 2 hours off per day, and you can complete a Hauser PD symptom diary, then you are likely highly suited for this clinical trial!

Subject of Study: Advanced Parkinson’s Disease
Length of Study: 18 months
Number of in-person visits: 10
Compensation: $75/visit completed, $750 total if entire study is completed.